Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Suviray 70mg Injection
Manufacturer/Marketed By : NOVARTIS INDIA LTD
$273.17 $251.32
Suviray 70 mg Injection contains the active component Erenumab, a monoclonal antibody used for the preventive treatment of migraines in adults. Migraine is a neurological disorder that causes recurring and...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
ERENUMAB
Active Pharmaceutical Ingredient
Suviray 70mg Injection
273.17$
251.32$
Suviray 70 mg Injection contains the active component Erenumab, a monoclonal antibody used for the preventive treatment of migraines in adults. Migraine is a neurological disorder that causes recurring and intense headaches, often with symptoms like nausea, sensitivity to light, and visual disturbances. For patients who have not responded well to other preventive medicines, Suviray provides an effective alternative. The recommended Suviray injection erenumab dosage should be taken under medical supervision to ensure safety and effectiveness in migraine prevention. Patients should be aware of Suviray injection uses migraine management, possible Suviray injection fatigue constipation side effects, and important Suviray injection contraindications. This medicine is not advised in children and adolescents under 18 years, while elderly individuals may need close monitoring. It is also essential to know Suviray injection pregnancy safety, as its use during pregnancy should only be considered if prescribed by a doctor. Proper Suviray injection storage conditions and awareness of the Suviray injection shelf life are necessary for maintaining its effectiveness. When comparing Suviray 70 mg Injection vs Aimovig or Suviray 70 mg Injection vs Galcanezumab, the choice depends on individual patient response and physician recommendation. Patients often ask Suviray injection how long it lasts, which may vary depending on individual metabolism and treatment schedules. For those concerned about affordability, the Suviray 70 mg injection price India may vary across pharmacies, and one can also buy Suviray 70 mg injection online from trusted sources. Additionally, it is useful to check the Suviray 70 mg injection review, details about the Suviray 70 mg injection manufacturer, available Suviray 70 mg injection substitute, and overall treatment benefits before starting therapy.
Active Pharmaceutical Ingredient
Uses
• Prevention of migraine in adults
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Suviray injection side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Suviray injection side effects are
Most Common Side Effects
• Serious allergic reactions
• Chronic constipation
Common Side Effects
• Constipation
• Itching
• Vomiting
• Fatigue
• Nausea
• Muscle spasms
• Injection site reactions
How To Use
The medicine will be prescribed to you by a healthcare professional in a hospital setting. Suviray 70 mg Injection is administered as a subcutaneous injection. It is injected under the skin, typically in the abdomen or thigh area, once a month. This route of administration allows the medication to be absorbed into the bloodstream and exert its preventive effects on migraines over time. It's important to follow the proper injection technique and guidelines your healthcare provider provides to ensure the medication is administered correctly and safely.
Safety Advice
• Breast Feeding: Consult your healthcare provider before using Suviray 70 mg Injection while breastfeeding. They will assess your situation, taking into account the severity of your migraines, available treatment alternatives, and potential risks to your nursing infant.
• Alcohol: Drinking too much alcohol may cause migraines or interfere with the effects of Suviray 70 mg Injection. For safety and efficacy, follow the advice of your healthcare provider.
• Liver: Individuals with severe liver may require dosage adjustments or careful monitoring when using Suviray 70 mg Injection. Consult your healthcare provider before starting this medication.
• Lungs: Consult your doctor if you have any lung diseases before starting the treatment with Suviray 70 mg Injection.
• Driving: Suviray 70 mg Injection does not have an impact on your ability to operate machinery and drive. See your healthcare provider before operating a vehicle if you suffer any side effects that could impair your ability to drive. When determining whether to drive after taking Suviray 70 mg Injection, put safety first.
• Pregnancy: It is generally advised to avoid using Suviray 70 mg Injection while pregnant unless the possible benefits outweigh the risks involved. It is necessary to inform your doctor if you are pregnant or planning to become pregnant Suviray injection pregnancy safety.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.